ASM 2023

Does Speed Matter? The Financial and Clinical Benefits of Rapid AST

Speakers: Thomas Kirn, MD PhD Dept. of Pathology and Medicine Rutgers Robert Wood Johnson Medical School | Eric Stern, PhD CTO, Selux Diagnostics

Despite the importance of antimicrobial susceptibility testing (AST) to infectious diseases patient care, current AST systems limit result speed, accuracy, and consistency. This forces an over-reliance on broad-spectrum antibiotics and contributes to antimicrobial resistance, the next global health crisis. While multiple rapid AST technologies are under development, they are restricted to bloodstream infections, so they cannot address most hospitalized patients with other infections. Join us to explore how rapid AST results lead to precise and fast antibiotic treatment, improved clinical outcomes, and reduced healthcare costs.

Download PowerPoint